Emmanuel Blot

A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer

Pierre Farmer, Hervé Bonnefoi, Pascale Anderle et al. · Nature Medicine · 2009 · 615 citations · Full text

Breast Oncology, Oncology, Engineering +11

Induction Chemotherapy Followed by Either Chemoradiotherapy or Bioradiotherapy for Larynx Preservation: The TREMPLIN Randomized Phase II Study

Jean Louis Lefèbvre, Y. Pointreau, Frédéric Rolland et al. · Journal of Clinical Oncology · 2013 · 410 citations · Full text

RETRACTED: Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial

Hervé Bonnefoi, Anil Potti, Mauro Delorenzi et al. · The Lancet Oncology · 2007 · 218 citations · Full text

Breast Oncology, Medicine, Pathology +9

Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial

J. Guigay, Anne Aupérin, Jérôme Fayette et al. · The Lancet Oncology · 2021 · 214 citations

Gortec 2014-01 Tpextreme, Neoadjuvant Therapy, Medicine +11

Intravenous Delivery of Anti-RhoA Small Interfering RNA Loaded in Nanoparticles of Chitosan in Mice: Safety and Efficacy in Xenografted Aggressive Breast Cancer

Emmanuel Blot, Linda L. Pritchard, Paule Opolon et al. · Human Gene Therapy · 2006 · 166 citations